• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER KNEE CREATIONS, INC. CPLT F&A KIT 3CC 11G END; SCP KIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER KNEE CREATIONS, INC. CPLT F&A KIT 3CC 11G END; SCP KIT Back to Search Results
Model Number N/A
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Pain (1994)
Date of Event 12/11/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Subject 09-005 underwent an initial subchondroplasty surgery on (b)(6) 2019.For this subject, two lesions were treated in the left distal fibula: one was treated anteromedial with 1 cc accufill mixed with saline, and the other was treated posterolateral with 2 cc accufill mixed with saline.Concomitant procedures were a deltoid ligament repair, impingement, osteophyte removal, synovectomy, syndesmosis reconstruction, fibular osteotomy/fixation, and proximal and distal bone grafts.There were no intraoperative complications reported.The patient experienced an increase in pain approximately three months post-operatively on (b)(6) 2019, but had also undergone an additional procedure on the index ankle in (b)(6) 2019.Zimmer knee creations was notified of the event on (b)(6) 2020.The event was evaluated by the health care professional as possibly related to the device and possibly related to the procedure, but stated that the increase is likely due to recovery from the more recent procedure.The subject has not received treatment for the pain increase at this time and the event is ongoing.Once additional information becomes available, an additional report will be submitted.The product was not returned for the investigation, as it remains implanted in the patient.
 
Event or Problem Description
Subject 09-005 adverse event increase in pain.
 
Event or Problem Description
Clinical subject (b)(6) adverse event increase in pain.
 
Additional Manufacturer Narrative
Clinical subject (b)(6) underwent the initial subcondroplasty procedure on (b)(6) 2019, and the surgical documentation for the event were provided.For this subject, two lesions were treated in the left distal fibula, one was treated anteromedial with 1 cc of accufill mixed with saline, and one was treated posterolateral with 2 cc accufill mixed with saline.Concomitant procedures were a deltoid ligament repair, impingement, osteophyte removal, synovectomy, synodemosis reconstruction, fibular osteotomy/fixation, and proximal and distal bone grafts.The patient experienced an increase in pain approximately 3-month post-op in (b)(6) 2019, but had also undergone an additional procedure on the index ankle in (b)(6) 2019.The event was evaluated by the investigator as possibly related to the device and procedure, but said the increase is likely due to recovery from the more recent procedure.The investigator has not yet evaluated intensity.Subject has not received treatment for the pain increase at this time and the event is ongoing.Numeric pain scores: 6/10, 1/10, 4/10, 8/10, 3/10 at baseline, 2 weeks, 6 weeks, 3 months, 6 months respectively.There is no other information available outside of the clinical adverse event report which states that the procedure is not directly related to the complaint incident but could possibly be related.There is no further evidence or information to determine cause of the event so the finding for this complaint is indeterminate.The nature of the reporting clinician on the adverse event report is not to rule out any possibilities but otherwise there is no supporting evidence or information to determine cause.The device was not returned for the investigation, as it remains implanted in the patient.The dhr for the finished goods were reviewed, and no anomalies related to the complaint condition were noted.
 
Additional Manufacturer Narrative
Per zimmer knee creations capa ca-05425, this medwatch was identified for remediation, as the products listed in d11 in the initial submission were components of the finished kit for which this medwatch was filed under and should not have been reported.
 
Event or Problem Description
Clinical subject (b)(6) adverse event increase in pain.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CPLT F&A KIT 3CC 11G END
Common Device Name
SCP KIT
Manufacturer (Section D)
ZIMMER KNEE CREATIONS, INC.
841 springdale drive
exton PA 19341
MDR Report Key9886119
Report Number3008812173-2020-00007
Device Sequence Number16826381
Product Code OJH
UDI-Device Identifier00889024205345
UDI-Public00889024205345
Combination Product (Y/N)N
Initial Reporter CountryCA
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 09/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date02/21/2022
Device Model NumberN/A
Device Catalogue Number514.303
Device Lot NumberKC05829
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Device Age6 MO
Event Location Hospital
Initial Date Received by Manufacturer 02/28/2020
Supplement Date Received by Manufacturer02/28/2020
02/28/2020
Initial Report FDA Received Date03/26/2020
Supplement Report FDA Received Date07/28/2020
09/14/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
N/A
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
PN 308.034.2 LN 40438; PN 308.034.2 LN 41311; PN 314.030.0 LN SA185024
Outcome Attributed to Adverse Event Other;
Patient Age34 YR
-
-